INVABlog

Chronic venous insufficiency (CVI) represents a progressive medical condition affecting approximately 25-40% of adults worldwide, with prevalence increasing dramatically with age. This complex vascular disorder

Peripheral arterial stents represent a cornerstone technology in the endovascular management of peripheral arterial disease, providing mechanical scaffolding to maintain vessel patency after intervention. Since

Pulmonary embolism (PE) represents a potentially life-threatening cardiovascular emergency that occurs when blood clots, typically originating from deep veins in the legs, travel through the

Subsegmental pulmonary embolism (SSPE) represents a unique diagnostic and therapeutic challenge in the spectrum of pulmonary thromboembolic disease. Defined as thrombi limited to the subsegmental

Catheter-directed thrombolysis (CDT) has emerged as an important therapeutic option in the management of pulmonary embolism (PE), bridging the gap between systemic anticoagulation and more

Inferior vena cava (IVC) filters represent an important therapeutic option in the management of venous thromboembolism (VTE), particularly for patients with contraindications to anticoagulation or

Pulmonary embolism (PE) represents a significant healthcare challenge, with complex presentations ranging from incidental findings to life-threatening cardiovascular collapse. The heterogeneous nature of PE, combined

Chronic thromboembolic pulmonary hypertension (CTEPH) represents a unique and potentially curable form of pulmonary hypertension that develops as a long-term complication of pulmonary embolism. This

Cancer and venous thromboembolism (VTE), including pulmonary embolism (PE), share a complex and bidirectional relationship that significantly impacts patient outcomes. Cancer patients face a substantially

Peripheral arterial disease (PAD) represents a significant global health challenge, affecting over 200 million people worldwide and serving as a powerful marker of systemic atherosclerotic